BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News Details
Lyka Labs Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
500259
ISIN Demat
INE933A01014
Book Value (Rs)
37.0210703
NSE Symbol
LYKALABS
Divident Yield %
0
Market Cap
(Rs In Cr.)
166
P/E (TTM)
0
EPS (TTM)
0
Face Value
(Rs)
10
Back
Lyka Labs reports consolidated nil net profit/loss in the December 2025 quarter
29-Jan-26   Hrs IST

Lyka Labs reported no net profit/loss in the quarter ended December 2025 as against net profit of Rs 2.70 crore during the previous quarter ended December 2024. Sales declined 9.08% to Rs 30.73 crore in the quarter ended December 2025 as against Rs 33.80 crore during the previous quarter ended December 2024.

ParticularsQuarter Ended
Dec. 2025Dec. 2024% Var.
Sales30.7333.80 -9
OPM %5.3715.36 -
PBDT1.995.41 -63
PBT-0.163.57 PL
NP02.70 -100

Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)